(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Twin Peaks, a sports bar chain, made its debut on the Nasdaq Thursday, marking the first restaurant IPO of 2025.

Companies should not minimize the extent of a material cybersecurity incident by omitting material facts regarding the scope ...

Twin Peaks – an American chain of sports bars and restaurants goes live on Nasdaq in what is the first restaurant debut of ...

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.

The lawyer behind a series of high-profile legal challenges to DEI practices is suing Bally’s and the city of Chicago over a $250 million IPO the suit says is unlawfully open only to people of color ...

IPO experts are expecting more companies to go public this year than last year, and restaurants including Panera and Fogo de ...

Taking yet another step in its preparations for its IPO, B2B marketplace unicorn OfBusiness has converted itself into a ...

Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...

Smithfield will not receive any proceeds from the sale of the shares by the selling shareholder. Acting joint lead ...